Pine Bridge Investments, L.P. Meridian Bioscience Inc Transaction History

Pine Bridge Investments, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$7.9 - $10.14 $36,600 - $46,978	-4,633 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$9.17 - $12.01 $16,203 - $21,221	1,767 Added 61.65%	4,633 $44,000
Q2 2019 Aug 13, 2019	SELL	$10.88 - $17.6 $192,706 - $311,731	-17,712 Reduced 86.07%	2,866 $34,000
Q1 2019 May 14, 2019	SELL	$15.51 - $17.61 $25,234 - $28,651	-1,627 Reduced 7.33%	20,578 $363,000
Q4 2018 Feb 13, 2019	SELL	$14.52 - $19.72 $39,044 - $53,027	-2,689 Reduced 10.8%	22,205 $386,000
Q3 2018 Nov 13, 2018	BUY	$14.85 - $16.35 $128,660 - $141,656	8,664 Added 53.38%	24,894 $371,000
Q2 2018 Aug 09, 2018	SELL	$13.8 - $16.8 $11,302 - $13,759	-819 Reduced 4.8%	16,230 $258,000
Q1 2018 May 14, 2018	SELL	$13.8 - $16.2 $291,704 - $342,435	-21,138 Reduced 55.35%	17,049 $242,000
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $446,472 - $520,610	32,950 Added 629.18%	38,187 $535,000
Q3 2017 Nov 13, 2017	SELL	$13.45 - $14.35 $4,344 - $4,635	-323 Reduced 5.81%	5,237 $75,000
Q2 2017 Aug 11, 2017	BUY	N/A	5,560	5,560 $87,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.